# Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke

> **NCT00790920** · PHASE3 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 492 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Desmoteplase
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00790920
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2014-07
- **Final completion:** —
- **Target enrollment:** 492 (ACTUAL)
- **Last updated:** 2015-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00790920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00790920, "Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00790920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*